USANA HEALTH SCIENCES INC (USNA) Stock Earnings Estimates
USA - New York Stock Exchange - NYSE:USNA - US90328M1071 - Common Stock
22.53 USD
+0.02 (+0.09%)
22.53 USD
0 (0%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 998.6M -15.84% | 921.01M -7.77% | 854.503M -7.22% | 943.52M 10.42% | 975.3M 3.37% | 1.035B 6.12% | |
| EBITDA YoY % growth | 121M -33.95% | 105.773M -12.58% | 80.863M -23.55% | 101.34M 25.32% | 111.94M 10.46% | 135.52M 21.06% | |
| EBIT YoY % growth | 107.6M -36.78% | 93.071M -13.50% | 66.324M -28.74% | 79.662M 20.11% | 76.296M -4.23% | N/A | |
| Operating Margin | 10.78% | 10.11% | 7.76% | 8.44% | 7.82% | N/A | |
| EPS YoY % growth | 3.59 -37.13% | 3.30 -8.08% | 2.60 -21.21% | 1.77 -31.74% | 1.99 12.07% | 2.87 44.10% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.42 -34.66% | 0.41 -44.11% | 0.45 -39.35% | 0.51 440.00% | 0.57 36.59% | 0.61 50.00% | 0.63 40.91% | 0.79 54.00% | 0.78 35.71% |
| Revenue Q2Q % growth | 230.48M 7.90% | 242.39M -2.86% | 228.61M -3.13% | 231.26M 8.07% | 235.59M 2.22% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 25.82M 13.50% | 23.843M -0.70% | 27.902M -14.93% | 27.735M 9.95% | 31.104M 20.46% | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | 20.4M 148.48% | 26.724M 70.53% | 15.3M -8.48% | 17.544M 1,333.33% | 18.87M -7.50% | N/A | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | -0.15 -126.79% | 0.48 | -0.63 | -131.29% |
| Q2 2025 Q2Q % growth | 0.74 37.04% | 0.55 | 0.19 | 34.35% |
| Q1 2025 Q2Q % growth | 0.73 -15.12% | 0.71 | 0.02 | 2.24% |
| Q4 2024 Q2Q % growth | 0.64 -26.44% | 0.50 | 0.14 | 28.18% |
| Q3 2024 Q2Q % growth | 0.56 -5.08% | 0.49 | 0.07 | 13.20% |
| Q2 2024 Q2Q % growth | 0.54 -39.33% | 0.66 | -0.12 | -18.68% |
| Q1 2024 Q2Q % growth | 0.86 -9.47% | 0.70 | 0.16 | 22.37% |
| Q4 2023 Q2Q % growth | 0.87 31.82% | 0.53 | 0.34 | 65.46% |
| Q3 2023 Q2Q % growth | 0.59 -24.36% | 0.65 | -0.06 | -9.12% |
| Q2 2023 Q2Q % growth | 0.89 -11.00% | 0.71 | 0.18 | 25.46% |
| Q1 2023 Q2Q % growth | 0.95 -17.39% | 0.78 | 0.17 | 21.59% |
| Q4 2022 Q2Q % growth | 0.66 -35.92% | 0.36 | 0.30 | 83.30% |
| Q3 2022 Q2Q % growth | 0.78 -42.65% | 0.91 | -0.13 | -13.98% |
| Q2 2022 Q2Q % growth | 1.00 -46.52% | 1.16 | -0.16 | -13.62% |
| Q1 2022 Q2Q % growth | 1.15 -20.69% | 1.16 | -0.01 | -1.10% |
| Q4 2021 Q2Q % growth | 1.03 -44.92% | 1.31 | -0.28 | -21.11% |
| Q3 2021 Q2Q % growth | 1.36 -5.56% | 1.33 | 0.03 | 2.56% |
| Q2 2021 Q2Q % growth | 1.87 41.67% | 1.75 | 0.12 | 6.90% |
| Q1 2021 Q2Q % growth | 1.45 17.89% | 1.51 | -0.06 | -4.27% |
| Q4 2020 Q2Q % growth | 1.87 | 1.46 | 0.41 | 28.50% |
| Q3 2020 Q2Q % growth | 1.44 | 1.29 | 0.15 | 11.60% |
| Q2 2020 Q2Q % growth | 1.32 | 1.10 | 0.22 | 19.83% |
| Q1 2020 Q2Q % growth | 1.23 | 0.85 | 0.38 | 44.42% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 214M 6.88% | 228.61M | -14.61M | -6.39% |
| Q2 2025 Q2Q % growth | 236M 10.87% | 229.7M | 6.3M | 2.74% |
| Q1 2025 Q2Q % growth | 249.539M 9.54% | 247.9M | 1.639M | 0.66% |
| Q4 2024 Q2Q % growth | 213.613M -3.38% | 213.02M | 593K | 0.28% |
| Q3 2024 Q2Q % growth | 200.221M -6.16% | 209.89M | -9.669M | -4.61% |
| Q2 2024 Q2Q % growth | 212.869M -10.64% | 225.41M | -12.541M | -5.56% |
| Q1 2024 Q2Q % growth | 227.8M -8.29% | 231.39M | -3.59M | -1.55% |
| Q4 2023 Q2Q % growth | 221.083M -3.03% | 216.65M | 4.433M | 2.05% |
| Q3 2023 Q2Q % growth | 213.365M -8.54% | 224.81M | -11.445M | -5.09% |
| Q2 2023 Q2Q % growth | 238.202M -9.94% | 235.77M | 2.432M | 1.03% |
| Q1 2023 Q2Q % growth | 248.4M -8.98% | 245.03M | 3.37M | 1.38% |
| Q4 2022 Q2Q % growth | 228M -14.70% | 207.86M | 20.14M | 9.69% |
| Q3 2022 Q2Q % growth | 233.3M -14.98% | 249.08M | -15.78M | -6.34% |
| Q2 2022 Q2Q % growth | 264.5M -21.47% | 273.82M | -9.32M | -3.40% |
| Q1 2022 Q2Q % growth | 272.9M -11.40% | 272.66M | 240K | 0.09% |
| Q4 2021 Q2Q % growth | 267.3M -13.91% | 277.37M | -10.07M | -3.63% |
| Q3 2021 Q2Q % growth | 274.4M -8.07% | 273.43M | 970K | 0.35% |
| Q2 2021 Q2Q % growth | 336.8M 30.04% | 339.27M | -2.47M | -0.73% |
| Q1 2021 Q2Q % growth | 308M 15.53% | 307.5M | 500K | 0.16% |
| Q4 2020 Q2Q % growth | 310.5M | 297.37M | 13.13M | 4.42% |
| Q3 2020 Q2Q % growth | 298.5M | 284.38M | 14.12M | 4.97% |
| Q2 2020 Q2Q % growth | 259M | 261.46M | -2.46M | -0.94% |
| Q1 2020 Q2Q % growth | 266.6M | 245.49M | 21.11M | 8.60% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | 8.11% | 0% | -33.97% |
| Revenue | -0.26% | 0.21% | -0.06% | -3.63% |